An Overview of Chemistry, Kinetics, Toxicity and Therapeutic Potential of Boldine in Neurological Disorders

被引:6
|
作者
Akotkar, Likhit [1 ]
Aswar, Urmila [1 ]
Ganeshpurkar, Ankit [2 ]
Raj, Ritik [3 ]
Pawar, Atmaram [4 ]
机构
[1] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmacol, Pune 411038, Maharashtra, India
[2] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmaceut Chem, Pune 411038, India
[3] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmaceut Biotechnol, Pune 411038, India
[4] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmaceut, Pune 411038, India
关键词
Alkaloids; Antioxidant; Boldine; Aporphine; Neuroprotective; Toxicity; SPINAL-CORD-INJURY; MICROSOMAL LIPID-PEROXIDATION; OXIDATIVE STRESS; IN-VITRO; ALKALOID BOLDINE; PEUMUS-BOLDUS; ANTIOXIDANT ACTIVITY; APORPHINE ALKALOIDS; STATUS EPILEPTICUS; CELL-DEATH;
D O I
10.1007/s11064-023-03992-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Boldine is an alkaloid obtained from the medicinal herb Peumus boldus (Mol.) (Chilean boldo tree; boldo) and belongs to the family Monimiaceae. It exhibits a wide range of pharmacological effects such as antioxidant, anticancer, hepatoprotective, neuroprotective, and anti-diabetic properties. There is a dearth of information regarding its pharmacokinetics and toxicity in addition to its potential pharmacological activity. Boldine belongs to the aporphine alkaloid class and possesses lipophilic properties which enable its efficient absorption and distribution throughout the body, including the central nervous system. It exhibits potent free radical scavenging activity, thereby reducing oxidative stress and preventing neuronal damage. Through a variety of neuroprotective mechanisms, including suppression of AChE and BuChE activity, blocking of connexin-43 hemichannels, pannexin 1 channel, reduction of NF-& kappa;& beta; mediated interleukin release, and glutamate excitotoxicity which successfully reduces neuronal damage. These results point to its probable application in reducing neuroinflammation and oxidative stress in epilepsy, Alzheimer's disease (AD), and Parkinson's disease (PD). Moreover, its effects on serotonergic, dopaminergic, opioid, and cholinergic receptors were further investigated in order to determine its applicability for neurobehavioral dysfunctions. The article investigates the pharmacokinetics of boldine and reveals that it has a low oral bioavailability and a short half-life, requiring regular dosage to maintain therapeutic levels. The review studies boldine's potential therapeutic uses and mode of action while summarizing its neuroprotective benefits. Given the favorable results for boldine as a potential neurotherapeutic drug in laboratory animals, more research is required. However, in order to optimise its therapeutic potential, it must be more bioavailable with fewer detrimental side effects.
引用
收藏
页码:3283 / 3295
页数:13
相关论文
共 50 条
  • [21] Potential therapeutic uses of BDNF in neurological and psychiatric disorders
    Nagahara, Alan H.
    Tuszynski, Mark H.
    NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (03) : 209 - 219
  • [22] Potential Therapeutic Role of Carnitine and Acetylcarnitine in Neurological Disorders
    Maldonado, Cecilia
    Vazquez, Marta
    Fagiolino, Pietro
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (12) : 1277 - 1285
  • [23] Potential therapeutic uses of BDNF in neurological and psychiatric disorders
    Alan H. Nagahara
    Mark H. Tuszynski
    Nature Reviews Drug Discovery, 2011, 10 : 209 - 219
  • [24] Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders
    Mishra, Awanish
    Mishra, Pragya Shakti
    Bandopadhyay, Ritam
    Khurana, Navneet
    Angelopoulou, Efthalia
    Paudel, Yam Nath
    Piperi, Christina
    MOLECULES, 2021, 26 (21):
  • [25] Harnessing Therapeutic Potentials of Biochanin A in Neurological Disorders: Pharmacokinetic and Pharmacodynamic Overview
    Kumar, Ankit
    Angelopoulou, Efthalia
    Pyrgelis, Efstratios-Stylianos
    Piperi, Christina
    Mishra, Awanish
    CHEMISTRY & BIODIVERSITY, 2024, 21 (08)
  • [26] Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders
    Gold, BG
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (10) : 2331 - 2342
  • [27] Molecular Mechanisms and Therapeutic Potential of α- and β-Asarone in the Treatment of Neurological Disorders
    Balakrishnan, Rengasamy
    Cho, Duk-Yeon
    Kim, In-Su
    Seol, Sang-Ho
    Choi, Dong-Kug
    ANTIOXIDANTS, 2022, 11 (02)
  • [28] Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders
    Sethiya, Neeraj Kumar
    Ghiloria, Neha
    Srivastav, Akanksha
    Bisht, Dheeraj
    Chaudhary, Sushil Kumar
    Walia, Vaibhav
    Alam, Md. Sabir
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (07) : 865 - 882
  • [29] NCAM Mimetic Peptides: Potential Therapeutic Target for Neurological Disorders
    Chengyan Chu
    Yue Gao
    Xiaoyan Lan
    Aline Thomas
    Shen Li
    Neurochemical Research, 2018, 43 : 1714 - 1722
  • [30] Potential Therapeutic Benefits of Honey in Neurological Disorders: The Role of Polyphenols
    Iftikhar, Arslan
    Nausheen, Rimsha
    Muzaffar, Humaira
    Naeem, Muhammad Ahsan
    Farooq, Muhammad
    Khurshid, Mohsin
    Almatroudi, Ahmad
    Alrumaihi, Faris
    Allemailem, Khaled S.
    Anwar, Haseeb
    MOLECULES, 2022, 27 (10):